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https://doi.org/10.1016/j.celrep.2021.109813SUMMARYA heterozygous missensemutation of the islet b cell-enrichedMAFA transcription factor (p.Ser64Phe [S64F])
is found in patients with adult-onset b cell dysfunction (diabetes or insulinomatosis), with men more prone to
diabetes than women. This mutation engenders increased stability to the unstable MAFA protein. Here, we
develop a S64FMafAmousemodel to determine how b cell function is affected and find sex-dependent phe-
notypes. Heterozygous mutant males (MafAS64F/+) display impaired glucose tolerance, while females are
slightly hypoglycemicwith improved blood glucose clearance. OnlyMafAS64F/+males show transiently higher
MafA protein levels preceding glucose intolerance and sex-dependent changes to genes involved in Ca2+
signaling, DNA damage, aging, and senescence. MAFAS64F production in male human b cells also accelerate
cellular senescence and increase senescence-associated secretory proteins compared to cells expressing
MAFAWT. These results implicate a conserved mechanism of accelerated islet aging and senescence in pro-
moting diabetes in MAFAS64F carriers in a sex-biased manner.INTRODUCTION
The large V-Maf avian musculoaponeurotic fibrosarcoma tran-
scription factor MafA is a pancreatic b cell-enriched protein
that is essential for activating rodent transcriptional programs
to promote b cell maturation and function, as can be measured
by glucose-stimulated insulin secretion (GSIS) (Artner et al.,
2008, 2010; Hang and Stein, 2011; Hang et al., 2014; Zhang
et al., 2005). The presence of MafA in only insulin+ b cells during
islet cell development and postnatally distinguishes it from other
important islet cell-enriched regulators (Golson and Kaestner,
2017; Hang and Stein, 2011; Pan and Wright, 2011; Shih et al.,
2013). For example, transcription factors such as Pdx1 and
Nkx6.1, which are expressed earlier and more broadly, also
have a profound impact on pancreas organogenesis, islet
b cell function, and whole-body glucose homeostasis in mice
(Madsen et al., 1997; Pan and Wright, 2011). Pdx1 is present in
both the exocrine and endocrine pancreas during developmentThis is an open access article under the CC BY-Nand then principally in islet b cells postnatally (Pan and Wright,
2011), while Nkx6.1 is found in endocrine progenitors and is later
restricted to b cells (Golson and Kaestner, 2017; Hang and Stein,
2011; Pan and Wright, 2011; Shih et al., 2013).
In contrast,mice lackingMafA (i.e.,MafA/ (Zhang et al., 2005),
MafADpanc (Artner et al., 2010; Hang et al., 2014), andMafADb (Cy-
phert et al., 2019; Luan et al., 2019) have normal pancreas forma-
tion and a relatively subtle influence on postnatal physiology,
primarily compromisingGSIS in a sex-independentmanner. How-
ever, MafA has been proposed to play a distinct late role in post-
natal islet b cell maturation, in part supported by observations
demonstrating that inducing MafA expression levels in normally
non-glucose-responsiveandMafALowneonatal rat islets increases
GSIS (Aguayo-Mazzucato et al., 2011), while compromising levels
reducemouse (Artner et al., 2010; Cyphert et al., 2019; Hang et al.,
2014; Luan et al., 2019; Zhang et al., 2005) and human (Guo et al.,
2013)b cell activity. A key regulatory role is also impliedby the abil-
ity of many islet-enriched transcription factors to coordinatelyCell Reports 37, 109813, October 12, 2021 ª 2021 The Authors. 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Male but not female MafAS64F/+
mice become glucose intolerant between 4
and 5 weeks of age
(A) Fasted male and female animals underwent
intraperitoneal glucose tolerance tests at 4 and
5 weeks of age. Male heterozygous (termed Het)
MafAS64F/+ mice (red line) had improved glucose
clearance at 4 weeks but become glucose intolerant
by 5 weeks. Female MafAS64F/+ mice (teal line) had
significantly lower fasting blood glucose levels and
improved glucose clearance at both time points.
(B) High glucose-stimulated insulin secretion in
isolated islets was impaired in male MafAS64F/+
samples at 5 weeks. Islets were incubated with
4.6 mM (low, LG) or 16.8 mM (high, HG) glucose for
1 h. Secreted insulin was normalized to DNA con-
tent.
(C) Islet insulin content trended lower in MafAS64F/+
males and was significantly decreased in females.
Levels were normalized to DNA content.
(D) Male (left panel) and female (right panel) islet b
cell area was reduced at 7 weeks in MafAS64F/+
mice. The area was calculated by dividing the total
insulin+ area by the total pancreatic area (eosin
staining) in pancreas sections obtained every 50 mm
multiplied by 100 to obtain percentage (%).
(E) Indicative of reduced islet area, the combined
islet b and a cell area was significantly reduced in
male and female MafAS64F/+ mice at 7 weeks.
(A–C) Two-tailed Student t test; *p < 0.05; **p < 0.01;
***p < 0.001.




OPEN ACCESSstimulate MafA gene transcription, including Pdx1 and Nkx6.1
(Raum et al., 2006, 2010).
Expression of MafB, the other large Maf family member pro-
duced in the islet, differs fromMafA in being produced in bothmu-
rine a and b cells developmentally (Cyphert et al., 2019; Hang and
Stein, 2011), then postnatally only in a cells and a subpopulation
of maternal b cells during pregnancy (Banerjee et al., 2016; Cy-
phert et al., 2019). Moreover, genetic studies have demonstrated
that MafB is dispensable in regulating adult murine islet b cell
function, except during pregnancy (Banerjee et al., 2016; Cyphert
et al., 2019). MafA expression during mouse b cell development
compensates for the absence of MafB, although glucagon secre-
tion from islet a cells is compromised (Conrad et al., 2016). In
addition, misexpressing MafB inMafADpanc b cells cannot rescue
MafA function (Cyphert et al., 2019). These results illustrate simi-
larities and differences between MafA and MafB in expression
and function in rodent islet cells.2 Cell Reports 37, 109813, October 12, 2021While most islet-enriched transcription
factors are produced in an analogous
fashion in rodents and humans, there are
unique differences in the temporal and islet
cell type-specific expression pattern of the
human MAFA and MAFB proteins. In hu-
mans, MAFA protein is not detected in the
b cell until 10 years of age, while MAFB
is present throughout the lifespan of humaninsulin+ b cells (Cyphert et al., 2019; Dai et al., 2012). These obser-
vations imply that humans have at least two postnatal b cell
populations (in terms of MAFA) capable of maintaining
euglycemia, represented by the juvenile (i.e., <10 years old and
MAFALow:MAFB+) and post-juvenile (R10 years old and
MAFAHigh:MAFB+) periods. In fact, independent studies have es-
tablished distinct molecular and functional properties of these
temporally produced human cell populations (Arda et al., 2016;
Arrojo E Drigo et al., 2019; Camunas-Soler et al., 2020) and an as-
sociation between MAFA levels and adult islet b cell functional
heterogeneity (Chen et al., 2019). MAFA and MAFB levels are
reduced in type 2 diabetic (T2D) islets (Guo et al., 2013), and (at
least) MAFA is particularly sensitive to oxidative stress and gluco-
toxic conditions (Harmon et al., 2005). While the role of MAFA or
MAFB has not been analyzed directly in intact human islets,
both are required for GSIS in the human EndoC-bH1 b cell line
(Scharfmann et al., 2014; Scoville et al., 2015). Moreover, we
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in human embryonic stemcell-derived b cells (Russell et al., 2020),
which is in stark contrast to its dispensable role in rodents (Bane-
rjee et al., 2016; Cyphert et al., 2019). These findings highlight spe-
cies-specific differences in MAFA and MAFB production and islet
cell distribution, likely implying that the homodimeric MAFB acti-
vator and the MAFA:MAFB heterodimeric activator provide
unique functional characteristics to human islet b cells.
Individuals carrying a heterozygous mutation in the MAFA
transactivation domain producing a substitution of the conserved
serine at position 64 with a phenylalanine (p.Ser64Phe [S64F])
develop either diabetes mellitus or insulinomatosis, a non-syn-
dromic condition of hyperinsulinemic hypoglycemia caused by
multiple insulin-secreting neuroendocrine tumors. The mean age
at diagnosis for both conditions is 38 years (Iacovazzo et al.,
2018). These results demonstrate that MAFA is a causative gene
for maturity-onset diabetes of the young (MODY), a collection of
monogenic diseases predominantly driven bymutations in essen-
tial islet-enriched transcription factors (Barbetti and D’Annunzio,
2018). Interestingly, diabetes is prevalent in male MAFAS64F car-
riers (i.e., 3:1), while insulinomatosis is more common in female
carriers (4:1) (Iacovazzo et al., 2018). In vitro analysis demon-
strated that the S64F substitution prevents a key priming phos-
phorylation event at position S65 in MAFA, which profoundly
increases the stability of the normally unstable MAFA protein by
affecting processes necessary for ubiquitin-mediated degrada-
tion (Iacovazzo et al., 2018).
Due to the rare detection of MAFAS64F-mediated diseases and
difficulty of performing mechanistic studies in a human context,
we used CRISPR-Cas9-based mutagenesis to establish a mouse
model (termed MafAS64F/+) harboring the same pathogenic single
base pair substitution (C>T) as human carriers. Diabetes-related
phenotypes were specifically associated with male MafAS64F/+
heterozygous mice by 5 weeks of age, which manifested glucose
intolerance due in part to a reduced glucose-stimulated b cell
Ca2+ response. These changes were preceded by an overt but
transient increase in MafA protein levels in islet b cells at 4 weeks.
In addition, the functional deficiencies in male MafAS64F/+ islet
b cells accompanied the induction of markers of DNA damage,
cell-cycle exit, senescence, and the senescence-associated
secretory phenotype (SASP) at 5 weeks, consistent with acceler-
ated cellular aging and senescence. In contrast, heterozygous
mutant female mice not only had lower fasting blood glucose
levels and improved glucose clearance but also did not display
any of the overt aging and senescence signatures of littermate,
heterozygous males. Expression of MAFAS64F in the male human
b cell line, EndoC-bH2, showed increased senescent gene
markers and secretion of human-specific SASP factors capable
of inducing senescence in a cell non-autonomous manner. These
results indicate that diabetes in human maleMAFAS64F carriers is
caused by the premature senescence and aging of islet b cells.
RESULTS
Male MafAS64F/+ mice are glucose intolerant due to
impaired insulin secretion
Since MafA is a primary regulator of glucose clearance and insu-
lin secretion in islet b cells (Hang and Stein, 2011), MafAS64F/+and wild-type (WT) littermates were subjected to glucose toler-
ance testing (GTT) and fasting blood glucose measurements at
various postnatal time points. While both male and female
MafAS64F/+ animals had improved glucose clearance at 4 weeks,
females also had modest fasting hypoglycemia (Figure 1A).
Strikingly, male MafAS64F/+ animals developed persistent
glucose intolerance beginning at 5 weeks of age, while females
continued to have improved glucose tolerance and lower fasting
blood glucose levels (Figure 1A). GTT results were stably main-
tained in male and female MafAS64F/+ mice (Figure S1). The
sex-dependent male phenotype was even more penetrant in ho-
mozygousMafAS64F/S64F mutants, as males displayed overt dia-
betes with elevated fasting glucose levels that progressively
worsened (Figures S2A and S2B). In contrast, the phenotype of
homozygous females was much more variable and largely com-
parable to WT littermates (Figure S2C). Because of the generally
poor survival of homozygous mutants postnatally (Figure S2D),
possibly resulting from severe neurodevelopmental defects
due to MafAS64F/S64F expression and its altered activity in the
central nervous system (Lecoin et al., 2010; Niceta et al.,
2015), all of the remaining experimentation was performed with
male and female heterozygous MafAS64F/+ mice.
Insulin secretion by ex vivo GSIS was impaired in 5-week-old
male MafAS64F/+ islets (Figure 1B), although insulin content
trended lower in male MafAS64F/+ islets and was significantly
reduced in female islets (Figure 1C). MafAS64F/+ female mice
appear to have lower fasting blood glucose levels (Figure 1A)
due to increased insulin secretion in both low (5.6) and high
(16.7) glucose conditions as determined by dynamic perifusion
assays (Figure S3A) and increased fasting serum insulin levels
(Figure S3B). Thus, 8- to 10-week old female MafAS64F/+ islets
had markedly improved 1st and 2nd phase GSIS properties
compared to controls in the perifusion assays, while males
MafAS64F/+ islets showed a mild improvement in this ex vivo sys-
tem, but not nearly to the levels found in females (Figure S3C).
Because of the counterregulatory effects of insulin on glucagon
hormone secretion (Franklin et al., 2005), we considered that
glucose-regulated glucagon levels may be altered in MafAS64F/+
mice. However, there was neither an obvious sex-dependent
impact on glucose-stimulated glucagon secretion nor a change
in glucagon content (Figures S3D and S3E). The islet a cell
area was also unchanged in both male and female MafAS64F/+
islets, although this was variable among animals (Figure S3F).
The insulin+ b cell area was reduced in male and female
MafAS64F/+ mice (Figure 1D), as were their combined b and a
cell areas and b cell number per islet section (Figures 1E and
S3H). The decrease in b cell area may be due to lower islet cell
proliferation rates in MafAS64F/+ mice relative to WT littermates
(Figure S3G). In addition, the changes in blood glucose levels
were not attributable to differences in peripheral tissue insulin
sensitivity or glucose uptake as insulin tolerance tests and
glycogen storage were both unchanged (Figures S4A and S4B).
Animal body weight was also not appreciably altered in
MafAS64F/+ mice, except for a small decrease in female
MafAS64F/+ mice at 5 weeks of age that disappeared by 6 weeks
(Figure S4C). These combined results suggested a fundamental
difference(s) inMafAS64F/+b cell activity between the sexes, result-
ing in their distinguishing ability to control glucose homeostasis.Cell Reports 37, 109813, October 12, 2021 3
Figure 2. MAFA protein levels were tran-
siently upregulated at 4 weeks in male Ma-
fAS64F/+ islets
(A) Immunostaining over the course of 3, 4, 5, 6, and
7 weeks revealed that MAFA protein staining in-
tensity only increased at 4 weeks of age in male
MafAS64F/+ (Het) islets.
(B) In contrast, MAFA staining intensity was un-
changed between femaleMafAS64F/+ and WT islets.
(C)MafAmRNA levels were significantly reduced at
4 and 5 weeks in both male and female MafAS64F/+
islet samples. Fold change shown relative to male




OPEN ACCESSBecause the sex hormones estradiol and testosterone affect
islet cell function (Gannon et al., 2018), we questioned whether
these hormones influenced the sex-biased phenotypes in
MafAS64F/+ mice. Both sexes achieved puberty appropriately
with fertility comparable to WT littermates (data not shown). Fe-
male MafAS64F/+ mice were ovariectomized to investigate
whether estrogen was regulating mutant sex-biased activity.
As expected, ovariectomy at 3 weeks of age produced glucose
intolerance in WT female mice by 4 weeks of age (Figure S5A). In
contrast, glucose tolerance was unaffected by ovariectomy in
age-matched female MafAS64F/+ mice (data not shown; Fig-
ure S5A). These results indicate that the effects of the MafAS64F
variant is dominant over the effects of estrogen deficiency on
glucose intolerance. Furthermore, testosterone levels were not
altered markedly in MafAS64F/+ males at both 4 and 5 weeks of
age and were similar to age-matched females in these pre-
and peripubertal mice (Figure S5B). The low circulating levels
of testosterone produced during this phenotypic window lowers
the likelihood of this hormone influencing MafAS64F actions.
Collectively, these results strongly suggest that MafAS64F reg-
ulates male and female islet b cells through common and distinct
mechanisms; however, these processes are not principally influ-
enced by the primary sex hormones.4 Cell Reports 37, 109813, October 12, 2021MafA protein levels are transiently
and profoundly upregulated before
the changes in glucose clearance in
male MafAS64F/+ islet b cells
TheMAFAS64F variant impairs a key,priming
phosphorylation event at position S65,
which blocks subsequent glycogen syn-
thase kinase 3 (GSK3)-mediated phosphor-
ylation at positions S61, T51, T57, and S49
in the transactivation domain. These
changes impedeubiquitin-mediatedprotein
degradation of MAFAS64F, and its stability is
dramatically increased when expressed in
the human EndoC-bH1 b cell line (Han
et al., 2007; Iacovazzo et al., 2018; Rocques
et al., 2007). Consequently, we predicted
that thismutation in the highly conserved re-
gion of the protein (Han et al., 2007; Iaco-
vazzo et al., 2018; Rocques et al., 2007)
would also increase MafA levels inMafAS64F/+ b cells. Surprisingly, we only found elevatedMafA pro-
tein immunostaining intensity in maleMafAS64F/+ islets at 4 weeks
of age (Figure 2A), 1 week before the onset of glucose intolerance
(Figure 1A). In contrast, MafA protein levels were not increased in
female MafAS64F/+ b cells at 4 weeks or any other analyzed time
point (Figure 2B). However, there was a roughly 3- to 5-fold
decrease in MafA transcript levels at 4 and 5 weeks of age in
both male and female MafAS64F/+ islets compared to WT litter-
mates (Figure 2C). The reduction in MafA gene expression
indicates that the more stable MafAS64F protein is acting in an
autoregulatory manner, likely by binding at the conserved MafA
binding site within the 50-flanking sequences of the Region 3 tran-
scription control domain (Raum et al., 2010).
Glucose- and potassium chloride (KCl)-stimulated
calcium handling were altered in both male and female
MafAS64F/+ islets
Toprovide an unbiased and comprehensive perspective over how
MafAS64F influences islet b cell gene expression, bulk RNA
sequencing (RNA-seq) was performed on isolated islets from
5-week-old WT and MafAS64F/+ male and female mice when a
clear delineation of phenotypes was observed. Female heterozy-
gous islets had 736 differentially expressed genes (DEGs) (337 up
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OPEN ACCESSand 399 down) compared to female WT islets, while males had
2,410 DEGs (2,031 up and 379 down) (Figure 3A). There were
also 391 DEGs that were similarly regulated between the sexes,
which were revealed by Gene Ontology analysis as having p <
0.05 and included factors associated with Ca2+ and K+ channels
important in controllingb cell function (Figures 3B and 3C). In addi-
tion, other voltage-dependent Ca2+ channel genes as well as
genes important to ion influx were also specifically upregulated
in maleMafAS64F/+ islets (Figure 3D), suggesting both sex-depen-
dent and sex-independent changes in ion flux inMafAS64F/+ islets.
Since glucose-induced elevations of cytoplasmic Ca2+
mediate insulin release (Bergsten et al., 1994), WT and
MafAS64F/+ islet Ca2+ handling was monitored in response to
glucose stimulation and KCl-induced depolarization. As
expected from the GSIS response of maleMafAS64F/+ islets (Fig-
ures 1B and S3C), their Ca2+ entry was significantly blunted rela-
tive to the WT islets in response to 11 mM glucose stimulation
(Figure 4A; represented by red trace in left panel and called a
‘‘non-responder’’). The glucose-stimulated Ca2+ oscillatory
pattern that is responsible for pulsatile insulin secretion was
also significantly diminished in these MafAS64F/+ islets (Fig-
ure 4A). In contrast, there appeared to be two distinct Ca2+
responsive islet populations in female MafAS64F/+ animals. One
was similar tomaleMafAS64F/+ islets in having a very limited initial
glucose response and minimal oscillatory behavior (i.e., Fig-
ure 4A, dark green representative trace in right panel and labeled
a non-responder). However, the remaining islets hadmore subtle
decreases in their initial response to 11 mM glucose, and subse-
quently oscillate with higher frequency but equivalent amplitude
toWT islets (Figure 4A, ‘‘responders,’’ teal representative trace in
right panel). The average peak amplitude of the initial glucose-
induced Ca2+ response was reduced in all male and female
MafAS64F/+ islets (Figure 4B). This suggests that the MafAS64F/+
female islet responders population is able to compensate
for the non-responders and maintain glucose tolerance in
MafAS64F/+ female mice, which would be predicted because
only a fraction (roughly 20%) of the b cell mass is thought to be
required to maintain glucose tolerance (Gale, 2002).
Male and female MafAS64F/+ islets also had disparate Ca2+ re-
sponses to KCl-mediated depolarization. The KCl-induced Ca2+
influx (DCa2+ after KCl application divided by baseline Ca2+) was
significantly reduced in male MafAS64F/+ islets when compared
to WT male islets (Figures 4C and S5C). Interestingly, however,
the female MafAS64F/+ islets showed greater KCl-induced Ca2+
influx when compared to WT female islets, which was observed
for both glucose-stimulated Ca2+ responders and non-re-
sponders (Figures 4C, S3A, and S5C). Importantly, female
MafAS64F/+ islets also showed greater baseline (5 mM glucose)
Ca2+ levels than WT female islets (Figure S5D), which is consis-
tent with the fasting hypoglycemia and increased fasting insulin
levels observed in femaleMafAS64F/+ mice (Figures 1A and S3B).
Only male MafAS64F/+ islets express markers of
accelerated cellular senescence and aging
Because 5-week-old male MafAS64F/+ islet b cells were not only
defined by a predominant, Ca2+ non-responsive population (Fig-
ures 4A and 4B) but also by glucose intolerance (Figure 1A), we
focused our attention on identifying molecular determinants totheir poor function. In addition to the previously illustrated gene
expression alterations involved inCa2+ signaling (index ranking 6,
Figure 5A), 5-week-old male MafAS64F/+ RNA-seq data revealed
the upregulation of manymetabolic pathway genes implicated in
cellular aging (e.g., index ranking pathways 4, 6, and 8) and
senescence (e.g., index ranking pathways 1, 2, 3, 5, 6, 7, and 8
in Figure 5A) (Basisty et al., 2018; Campisi and d’Adda di Faga-
gna, 2007; Coppé et al., 2010; Franceschi et al., 2018; Greenhill,
2019; Kabir et al., 2016; Mancini et al., 2012; Martin and Bernard,
2018). Furthermore, the preponderance of upregulated genes
detected by RNA-seq implied that MafAS64F is acting as a domi-
nant activator in (at least) male MafAS64F/+ islets (Figure 3A).
Cellular senescence is a durable, cell-cycle arrest response
that regulates cell fate specification, tissue patterning, and func-
tion during development, cell maturation, and organismal aging
(Campisi, 2014; Gorgoulis et al., 2019; Helman et al., 2016; Her-
ranz andGil, 2018). It is also induced in a variety of disease states
and primarily serves as a stress response to many internal and
external insults (Gorgoulis et al., 2019; Herranz and Gil, 2018).
The importance of premature aging and senescence in driving
male MafAS64F/+ b cell dysfunction was supported by the many
genes associated with these responses, including those control-
ling Ca2+ signaling (Figure 3D), aging (Figure 5B), the DNA
damage response (DDR; Figure 5C), SASP (Figure 5D), and cyto-
kine-cytokine receptor interactions (Figure 5E). As expected, the
expression of candidate genes linked to aging and senescence
were increased in 5-week-old maleMafAS64F/+ islets (Figure 5F),
although not before manifesting glucose intolerance in 4-week-
old males (Figures 1A and 5F). Importantly, these genes were
largely unaltered in MafAS64F/+ female islets (Figure S6A),
although many other female candidate DEGs were validated by
qPCR (Figures 3D, 5B–5F, S6B, and S6C).
Senescent cells undergo a progression of changes after an
initial insult: early initiation of cellular arrest by activation of
cell-cycle inhibitors (e.g., p53, p21, and/or p16) and DDR re-
sponses in an attempt to regain homeostasis (Gorgoulis et al.,
2019; Herranz and Gil, 2018). DDR can be characterized by
markers such as phosphorylated histone H2AX (gH2AX) and
53BP1 recruitment to chromatin. We identified increased immu-
nostaining for the gH2AX marker for DNA double-strand breaks,
the P53 binding protein-1 (53BP1) DNA damage marker (Schultz
et al., 2000), and the p21 cell-cycle arrest and senescence
marker (Fang et al., 1999) in 5-week-old MafAS64F/+ male, but
not female islets (Figures 6A–6C and S7A–S7C). While only 3%
of the male WT islets showed >10% p21+ b cells, this proportion
increased to 37% (including 15%with >20%p21+ b cells) inmale
MafAS64F/+ islets (Figure 6C, right panel).
Apoptosis was not induced in response to DNA damage in
either male or female MafAS64F/+ islets, as determined by the
inability to detect islet TUNEL+ cells between 4 and 7 weeks
of age (data not shown; Figure S7F). Induction of anti-apoptosis
genes (e.g., the BCL2 family members; Figure 5F) and resis-
tance to apoptosis are consistent with the senescence pheno-
type (Herranz and Gil, 2018; Thompson et al., 2019). In fact, key
markers of senescence, such as decreases in LaminB1 mRNA
and protein (Figure 6D) (Freund et al., 2012) and increased
endogenous senescence-associated b-galactosidase (SA-
b-gal) staining was detected in male MafAS64F/+ islets at levelsCell Reports 37, 109813, October 12, 2021 5
Figure 3. Male and female MafAS64F/+ islet cells regulate a common and distinct set of genes associated with Ca2+ and K+ channel activity
(A) The Venn diagram illustrates the total number of RNA-seq-identified genes differentially up- or down-regulated between 5-week-oldWT andMafAS64F/+ islets.
(B) Gene Ontology (GO): molecular function analysis (p < 0.05) of the 391 genes commonly up- or down-regulated inMafAS64F/+ (Het) islets revealed alterations in
multiple ion channel activity pathways.
(C) Heatmaps showing channel gene expression changes common between male and female MafAS64F/+ islets.
(D) Heatmap of Ca2+ signaling pathway genes uniquely increased in male MafAS64F/+ islets identified by Kyoto Encyclopedia of Genes and Genomes (KEGG)
analysis (also see Figure 5A). False discovery rate (FDR) < 0.05.
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Notably, SA-b-gal was undetectable at 4 weeks in male
MafAS64F/+ islets, a time point before b cell dysfunction or
ever in female MafAS64F/+ islets, nor was LaminB1 expression
decreased in female MafAS64F/+ islets (Figures 6D–6F, and
S7D and S7E). These results illustrate a novel sex-dependent
pathophysiology of accelerated b cell aging and senescence
that contributes to glucose intolerance in MafAS64F/+ males.6 Cell Reports 37, 109813, October 12, 2021Human EndoC-bH2 b cells expressing MAFAS64F show
increased markers of cellular senescence and a
functional senescence-associated secretory phenotype
Human EndoC-bH2 cells were transduced with human
MAFAWT or MAFAS64F expression constructs using lentivirus
to investigate whether cellular senescence could be prema-
turely induced in human b cells. Immunoblot analysis of
protein extracts from these EndoC-bH2 cells confirmed the
Figure 4. Glucose-induced Ca2+ oscillations
and KCl-induced Ca2+ responses are altered
in MafAS64F/+ islets
(A) Representative Fura2 traces show loss of the b
cell glucose-induced Ca2+ oscillations (11 mM
glucose [G]) in 5-week-old male MafAS64F/+ (Het)
islets (red line, ‘‘non-responders’’). Female Ma-
fAS64F/+ islets had 2 different functionally responsive
islet populations (‘‘responders,’’ teal line; non-re-
sponders, green line).
(B) Quantitation of male (left; 2-tailed Student
t test; ***p < 0.001) and female (right; 1-way
ANOVA; ****p < 0.0001) islets showed reduced
cytoplasmic Ca2+ following stimulation with
11 mM glucose. The average peak amplitude was
quantitated by dividing the first peak DCa2+ after
11 mM glucose application by the baseline
response at 5 mM glucose.
(C) The Ca2+ response to 30 mM KCl is reduced in
male MafAS64F/+ islets but increased in female
MafAS64F/+ islets. Representative traces for this
experiment are shown in Figure S8. Two-tailed
Student t test; **p < 0.01; ***p < 0.001.
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MAFAS64F (Figure S8A) (Iacovazzo et al., 2018). As in our
MafAS64F/+ mouse model, MAFAS64F-producing cells had
significantly increased SA-b-gal, p21, and 53BP1 expression
and decreased LaminB1 expression compared to those ex-
pressing the human MAFAWT protein (Figures 7A–7D and
S8B). Gene expression analysis of MAFAS64F-expressing
b cells showed changes consistent with senescence markers
identified in male MafAS64F/+ mice (i.e., increased p21,
increased BCL2, and decreased LMNB1) and decreased
expression of MAFB (Figure 7C), a transcription factor not
produced in rodent islet b cells postnatally (Conrad et al.,
2016). As found in male MafAS64F/+ mutant mouse islets, over-
expressing MAFAS64F in human EndoC-bH2 b cells caused
misexpression of a number of critical calcium channel genes,
including CACNA1A, CACNA1C, CACNA1E, and CACNA1G
without altering insulin secretion machinery gene expression
(Figure S8C).
Progression of senescence includes the development of
SASP factors, which upon secretion induce senescence by re-
programming neighboring cells in a cell non-autonomous
manner (Gorgoulis et al., 2019; Herranz and Gil, 2018). To
determine whether SASP factors are released by human cells
expressing MAFAS64F, control medium or conditioned media
(CM) collected from EndoC-bH2 cells expressing either
MAFAWT or MAFAS64F was applied to untransduced EndoC-
bH2 cells (Figure 7E). Notably, SASP genes identified in
male MafAS64F/+ mice were not increased in EndoC-bH2
cells in response to MAFAWT or MAFAS64F CM; however,
human-specific SASP markers in gene families related toC
those identified in MafAS64F/+ male mice
were specifically increased by MAFAS64F
CM (Figure 7E). These results illustrate
the ability of MAFAS64F to promote
cellular senescence in human b cellsand to generate a functional, human b cell SASP via spe-
cies-specific mediators.
DISCUSSION
Post-translational modifications of the islet-enriched MAFA pro-
tein are critical for regulating its activity, stability, and cellular
localization for appropriate b cell function (Guo et al., 2009,
2010; Han et al., 2007; Iacovazzo et al., 2018; Rocques et al.,
2007). Here, we have developed a mouse model of the human
MAFAS64F variant to understand mechanistically the sex-biased
pathophysiological outcomes of MODY or insulinomatosis in
affected heterozygous human carriers (Iacovazzo et al., 2018).
Significantly, the physiological outcomes of MafAS64F/+ mice
appear to mimic the outcomes expected in human subjects,
with glucose intolerance in males and improved glucose clear-
ance and hypoglycemia in females.
This mutation blocks a key priming phosphorylation event at
S65, which normally directs post-translational modifications
affecting MAFA protein stability (Guo et al., 2009; Han et al.,
2007; Rocques et al., 2007), transactivation (Han et al., 2007;
Rocques et al., 2007), oncogenesis (Rocques et al., 2007), and
DNA binding (Guo et al., 2010). These modifications are coupled
to two antagonistic regulatory processes: increased transactiva-
tion activity and ubiquitin-mediated degradation (Rocques et al.,
2007), illustrating that impeccable regulation of this protein is
linked to islet b cell health. Earlier in vitro analysis demonstrated
that the MAFAS64F variant converted this normally unstable pro-
tein (t1/2 30 min) to a very stable form (t1/2 R4 h) (Iacovazzo
et al., 2018). However, both male and female MafAS64F/+ miceell Reports 37, 109813, October 12, 2021 7
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OPEN ACCESShad similar improvements in glucose tolerance at 4 weeks,
before overt and transient elevation in protein levels in onlymales
(Figures 1 and 2). Notably, this increase in MafAS64F protein
levels preceded glucose intolerance seen by 5 weeks of age in
males, while females continued to be modestly hypoglycemic,
with improved glucose clearance. The changes in male and fe-
male MafAS64F/+ b cell activity were maintained throughout the
period of analysis despite the presence of WT-like protein levels
after 5 weeks. However, we propose that MafAS64F is more
abundantly and persistently produced than MAFAWT throughout
the lifetime of the b cell despite similar protein levels because of
3- to 5-fold lower MafA mRNA levels in male and female
MafAS64F/+ islets in relation to the WT islets (Figure 2C). In line
with this observation, human MAFA protein levels were largely
unchanged by immunohistochemistry between the normal and
insulinoma b cells of MAFAS64F patients (Iacovazzo et al., 2018).
Our examination of ovariectomized female MafAS64F/+ mice
suggested that the estrogen sex hormone did not have a direct
regulatory role, so it is presently unclear what factors are control-
ling the sexually dimorphic phenotypes of MafAS64F mutant
mice. Since MAFAS64F-induced disease is not observed until
38 years of age in both sexeswithout reports of affected puber-
tal development (Iacovazzo et al., 2018), we believe that neither
estrogen nor testosterone have an impact on the divergent dis-
ease processes in humans. Instead, we propose that future ef-
forts focus on determining whether sex chromosome-linked
genes are influenced by MAFAS64F, such as the X chromo-
some-linked candidate genes found differentially expressed in
5-week-old MafAS64F/+ male islets (Figure S9A).
Bulk RNA-seq analysis of 5-week-old male and female
MafAS64F/+mouse islets illustrated similar dysregulation of genes
involved in b cell identity and ion channel function (Figures 3,
S9B, and S9C). For example, the expression of several markers
of b cell maturation were diminished in bothMafAS64F/+male and
female islets (Figures S9B and S9C), including the Mnx1 (Pan
et al., 2015) and Pdx1 transcription factors as well as the Ucn3
neuropeptide (van der Meulen et al., 2015). In addition, the
expression of both sex-dependent and sex-independent genes
involved in Ca2+ responses were identified (Figure 3). Accord-
ingly, functional analyses after glucose stimulation revealed
dysfunctional Ca2+ responses. While all male 5-week-old
MafAS64F/+ islets appear to have severely blunted glucose-
induced Ca2+ responses (called non-responders in Figure 4),
females contained both non-responder and unique responder is-
lets with higher frequency oscillations in response to glucose.
Presumably, responder islets mediate the high basal glucose-
induced insulin secretion properties that are characteristic of
female MafAS64F/+ islets (Figures 4A and S3), while downstream
effectors of Mnx1 and Pdx1 activation that are involved in cell
signaling (e.g., Gcgr, Glp1r), secretion (Syt2, Ucn3, Ins1, Ins2),
and ion channel activity contribute to b cell non-responderFigure 5. Male MafAS64F/+ islets display increased expression of aging
(A) KEGG analysis of the 1,842 genes specifically upregulated in 5-week-old ma
(B–E) Heatmaps reveal male MafAS64F/+ islets have increased expression of pa
cytokine receptor interactions. FDR < 0.05.
(F) qRT-PCR confirmation of pathway gene changes in 5-week-old male MafAS
MafAS64F/+ islets, with the exception of Cdkn1a (p21) upregulation (hash-markeddysfunction (Blum et al., 2014; Gilbert andBlum, 2018; Jacobson
and Shyng, 2020; Kalwat and Cobb, 2017).
Because of the heterogeneity of the Ca2+ signaling changes in
female MafAS64F/+ islets, we narrowed our focus to determine
possible mechanisms contributing to the MafAS64F-induced dia-
betic phenotype in males. Future single-cell sequencing efforts
could reveal the factors regulating the interplay of distinct
responder and non-responder islet b cell populations of
MafAS64F/+ females as well as their relative homogeneity in
male non-responder islets. Importantly, our results clearly
show that the many gene products associated with male
MafAS64F/+ b cell inactivity are not made in female heterozygotes
(Figures 5 and S6). As divergent regulation of metabolism be-
tween the sexes in aging and disease is increasingly recognized
(Sampathkumar et al., 2020), MAFAS64F may provide a penetrant
model to study sex-dependent effects on b cell health.
As expected, dynamic perifusion studies showed a marked
reduction in baseline and stimulated insulin secretion in male
compared to female MafAS64F/+ islets (Figure S3). However, the
mildly elevated insulin secretion levels of 10- to 12-week-old
male MafAS64F/+ islets appears at odds with the impairment in
static insulin secretion at 5 weeks and temporally stable glucose
intolerance levels (Figure 1). We propose that the age of the
mutant mice may account for this discrepancy. Potentially, the
older and more active male b cells ‘‘compensate’’ for the less
active 5-week-old cells that were affected by the SASP factors
secreted at the onset of glucose intolerance. Future studies
will be focused on directly determining whether functionally
andmolecularly distinct b cell populations are progressively pro-
duced upon MAFAS64F exposure.
Since Ca2+ release in MafAS64F/+ male islets appeared to
contribute to b cell inactivity, we focused on understanding
how this process was affected in this context. Our results have
demonstrated that MafAS64F produces premature aging and
senescence signatures in male murine b cells and human En-
doC-bH2 cells (Figures 5, 6, and 7). In contrast, neither an aging
nor senescence signature was observed in female murine b cells
expressingMafAS64F (Figures S6 and S7). Future studies will also
investigate whether changes in Ca2+ handling occurs before or
after MafAS64F/+ male islets transition to a senescent phenotype
asCa2+ is also implicated in cellular senescence (Martin and Ber-
nard, 2018).
Unlike the temporary cell-cycle arrest of quiescence, senes-
cence is thought to be irreversible and refractory to mitogenic
stimuli. Senescent cells undergo a progression of changes after
early insult, including cell-cycle arrest by the activation of inhib-
itors (i.e., p53, p21, and/or p16, among others; Figures 5, 6, and
7) and DDR responses (Gorgoulis et al., 2019; Herranz and Gil,
2018). Progression to senescence involves chromatin remodel-
ing to influence gene expression, metabolism, autophagy, and
SASP, with the release of a heterogeneous mix of SASP effector, DDR, SASP, and cytokine pathway gene signatures
le MafAS64F/+ (Het) islets.
thway genes associated with (B) aging, (C) DDR, (D) SASP, and (E) cytokine-
64F/+ islets (solid bars). Gene expression was unchanged at 4-week-old male
bars). Two-tailed Student t test; *p < 0.05; **p < 0.01.
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OPEN ACCESSproteins influencing neighboring cells in a cell non-autonomous
manner (Gorgoulis et al., 2019; Herranz and Gil, 2018). Terminal
senescence from persistent damage involves autocrine and
paracrine SASP amplification, loss of nuclear integrity, and
diversification of the SASP phenotype (Gorgoulis et al., 2019).
Notably, senescence-associated SA-b-gal staining was not
induced in 4-week-old MafAS64F/+ b cells, just 1 week before
the detection of glucose intolerance (Figures 1 and 6).
Ultimately, senescent cells become resistant to apoptosis by
the upregulation of anti-apoptotic proteins, such as those in
the BCL2 family, and are often cleared by immune cells (Gorgou-
lis et al., 2019; Herranz and Gil, 2018). Interestingly, effective
clearance of b cells is not apparent in MafAS64F/+ male islets as
we see accumulation of senescent cells, and there was no evi-
dence of b cell death or immune cell infiltration (data not shown;
Figures 6 and S7F). Senescent cells can play a causal role in ag-
ing-related pathology (van Deursen, 2014), and targeted removal
of senescent cells can improve health span and reduce the inci-
dence of aging-related diseases (Baker et al., 2011, 2016; Chang
et al., 2016; Childs et al., 2016). Independent studies have shown
that removal of the rare, senescent b cells in mouse models of
T1D and T2D helps restore b cell function and glucose homeo-
stasis in vivo (Aguayo-Mazzucato et al., 2019; Thompson et al.,
2019). These senescent b cells showed distinct SASP signatures
depending onmodeling context (T1D versus T2D) (Aguayo-Maz-
zucato et al., 2019; Thompson et al., 2019), and these signatures
were also species dependent such that only a subset of SASP
mediators identified in respective mouse models were detected
in human, diabetic islets (Aguayo-Mazzucato et al., 2019;
Thompson et al., 2019).
Importantly, up to 50%–60% of human T2D b cells were
shown to be senescent (Aguayo-Mazzucato et al., 2019),
compared to their rare occurrence in previously described
mouse models (Aguayo-Mazzucato et al., 2019; Thompson
et al., 2019). This rate of b cell senescence is comparable to
that found in MafAS64F/+ male islets, suggesting that this variant
models the widespread b cell senescence in human T2D (Fig-
ure 6). In fact, MAFAS64F expression produced senescence in hu-
man EndoC-bH2 b cells with the development of a functional
SASP. Treatment with CM from MAFAS64F-expressing EndoC-
bH2 cells induced b cell senescence andSASP factor expression
differently from those identified inMafAS64F/+ male mouse islets,
albeit from similar molecular families. In summary, these studies
implicate MAFAS64F-induced senescence factors in causing b
cell dysfunction and open doors to the identification of b cell
senescence signatures across etiologies of diabetes (Figure 7F).
Human and rodent islets differ substantially in architecture,
cell composition, proliferative capacity, islet amyloid formation,
antioxidant enzyme levels, and, most significantly for the results
described herein, MAFA and MAFB transcription factor expres-Figure 6. DNA damage and senescence markers are increased in dysf
(A–C) gH2AX staining (A) and 53BP1 (B), markers of DNA double-strand breaks,
Male MafAS64F/+ islets had a significant increase in the proportion of islets with >
(D) Male MafAS64F/+ islets showed reduced LaminB1 protein (left) and mRNA (rig
(E and F) SA-b-gal was not produced in 4-week-old male MafAS64F/+ islets, but w
MafAS64F/+ islets was of similar intensity to 10- to 12-month-old WTmale mouse is
3–4). Two-tailed Student t test; **p < 0.01; scale bar, 50 mm.sion (Bosco et al., 2010; Brissova et al., 2005; Butler et al., 2007;
Cabrera et al., 2006; Dai et al., 2012; Fiaschi-Taesch et al., 2010;
Henquin et al., 2006; Tyrberg et al., 2001). Because MafA is ex-
pressed at the onset of rodent b cell formation during embryo-
genesis, but not until 10 years of age in humans (Cyphert et al.,
2019; Dai et al., 2012; Hang and Stein, 2011), we appreciate
that some of the observations made in MafAS64F/+ mice will not
be directly relevant to the human disease. For example, since
substantial b cell proliferation ceases in humans before MAFA
expression (Cyphert et al., 2019; Dai et al., 2012; Hang and Stein,
2011), the decreased islet cell proliferation observed in male and
female MafAS64F/+ mice may not be directly relevant in humans.
We also did not expect to find that MafAS64F/+ male mice would
manifest the overt fasting hyperglycemia seen in affected hu-
mans (Iacovazzo et al., 2018), since only 1 of the 7 human
MODY transcription factors has a phenotype in heterozygous
mice comparable to human carriers (i.e., Pdx1 (Ahlgren et al.,
1998)). As found in other studies of MODY transcription factor
function in mice, only the homozygous (male) MafAS64F/S64F
mice manifested an explicit elevation in fasting blood glucose
levels and glucose intolerance, which worsened with age (Fig-
ure S2). MafAS64F presumably represents another example of
how gene dosage of critical regulatory gene variants affects islet
cell health in a species-specific manner.
It is also likely that the unique requirement of MAFB in human
(but not rodent) b cells influences the effects of MAFAS64F in
human carriers. The human MAFAS64F:MAFB heterodimeric acti-
vator could impart a unique influence on b cells compared to the
mouse MafAS64F:MafA homodimeric activator (Cyphert et al.,
2019; Hang and Stein, 2011), whichmay explain why neuroendo-
crine tumors and overt hypoglycemia was not observed in aged
MafAS64F/+ female mice (data not shown). Notably, MAFB was
recently shown to be essential for the formation of human embry-
onic-derived b cells and insulin production (Russell et al., 2020),
whereas there is no phenotype associated with the loss of MafB
in mouse islet b cells except during pregnancy (Cyphert et al.,
2019). Thus,we believe that it will be important to extend the anal-
ysis of MAFAS64F control to human islets—acutely in vitro and
chronically after the transplantation of human pseudoislets into
immunocompromisedmice to directly determine its effect in vivo.
Such studies should generate keen insight into unique, species-
specific, age-dependent, and sex-biased molecular and genetic
mechanisms controlling human islet b cell activity.STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
d KEY RESOURCES TABLEunctional male MafAS64F/+ islets
and p21, a cell-cycle inhibitor (C), were present in male MafAS64F/+ (Het) islets.
10% p21+ cells.
ht).
as detected in MafAS64F/+ males by 7 weeks. (E) The SA-b-gal in 7-week-old
lets. (F) The proportion of SA-b-gal+ islets was quantitated for each sample (n =
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Figure 7. Human b cells expressing MAFAS64F demonstrate accelerated senescence and a species-specific SASP signature
(A) SA-b-gal staining on EndoC-bH2 cells transduced to express WT MAFA or MAFAS64F and stained for MAFA (red). Scale bar, 100 mm.
(B) Inset areas outlined in boxes in (A) are magnified in the left panel. Scale bar, 25 mm. b-gal+ area was significantly increased in MAFAS64F cells (right panel).
(C) Human expression of b cell-enriched proteins and senescence associated proteins identified in male MafAS64F/+ mice. Two-tailed Student t test; *p < 0.05;
**p < 0.01.
(legend continued on next page)
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also thank Drs. Raphaël Scharfmann and Phillippe Ravassard for generously
providing EndoC-bH2 cells. Imaging was performed with NIH support from
the Vanderbilt University Medical Center Cell Imaging Shared Resource (NCI
grant CA68485; NIDDK grants DK20593, DK58404, and DK59637; NICHD
grant HD15052; and NEI grant EY08126). Islet hormone analysis was per-
formed in the Vanderbilt University Medical Center Islet Procurement and
Analysis Core (NIH DK20593) and the Vanderbilt University Neurochemistry
Core (NIH U54 HD083211). MafAS64F-expressing mice were produced in
the Diabetes Research Center Animal Studies Core at the University of Mich-
igan, which is supported by NIH P30 DK020572.
AUTHOR CONTRIBUTIONS
E.M.W., J.C., X.T., and R.S. designed the initial experiments. E.M.W., J.C.,
X.T., M.G., and J.-H.L. executed and analyzed the experiments, with input(D) Immunostaining for senescence markers p21 (green) was increased and Lam
(E) CM from WT MAFA or MAFAS64F-expressing EndoC-bH2 cells were collecte
regulated in male MafAS64F/+ mice were not identified in EndoC-bH2 cells. How
identified in this context. N.D., not detectable. One-way ANOVA; *p < 0.05; **p <
(F) Schematic of temporal senescence and aging responses in MafAS64F-expre
molecular insults to induce premature senescence marked by cell-cycle arrest, s
associated secretory phenotype (SASP, pink secretory factors), resulting in impair
amplification and diversification.from S.Y., D.I., F.M.-J., S.E.F., M.K., J.S., D.A.J., and R.S. The manuscript
was principally written by E.M.W., J.C., X.T., and R.S., although all of the au-
thors have reviewed versions. R.S. is the guarantor of this work and as such
had full access to all of the data in the study and takes responsibility for the
integrity of the data and the accuracy of the data analysis.
DECLARATION OF INTERESTS
The authors declare no competing interests.
INCLUSION AND DIVERSITY
We worked to ensure sex balance in the selection of non-human subjects. We
worked to ensure diversity in experimental samples through the selection of
the cell lines. We worked to ensure diversity in experimental samples through
the selection of the genomic datasets. While citing references scientifically
relevant for this work, we also actively worked to promote gender balance in
our reference list. The author list of this paper includes contributors from the
location where the research was conducted who participated in the data
collection, design, analysis, and/or interpretation of the work.
Received: March 4, 2021
Revised: July 21, 2021
Accepted: September 17, 2021
Published: October 12, 2021
REFERENCES
Aguayo-Mazzucato, C., Koh, A., El Khattabi, I., Li, W.C., Toschi, E., Jermendy,
A., Juhl, K., Mao, K., Weir, G.C., Sharma, A., and Bonner-Weir, S. (2011). Mafa
expression enhances glucose-responsive insulin secretion in neonatal rat b
cells. Diabetologia 54, 583–593.
Aguayo-Mazzucato, C., Andle, J., Lee, T.B., Jr., Midha, A., Talemal, L., Chi-
pashvili, V., Hollister-Lock, J., van Deursen, J., Weir, G., and Bonner-Weir,
S. (2019). Acceleration of b cell aging determines diabetes and senolysis im-
proves disease outcomes. Cell Metab. 30, 129–142.e4.
Ahlgren, U., Jonsson, J., Jonsson, L., Simu, K., and Edlund, H. (1998). b-cell-
specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the b-cell
phenotype and maturity onset diabetes. Genes Dev. 12, 1763–1768.
Arda, H.E., Li, L., Tsai, J., Torre, E.A., Rosli, Y., Peiris, H., Spitale, R.C., Dai, C.,
Gu, X., Qu, K., et al. (2016). Age-Dependent Pancreatic Gene Regulation Re-
veals Mechanisms Governing Human b Cell Function. Cell Metab. 23,
909–920.
Arrojo E Drigo, R., Lev-Ram, V., Tyagi, S., Ramachandra, R., Deerinck, T.,
Bushong, E., Phan, S., Orphan, V., Lechene, C., Ellisman, M.H., and Hetzer,
M.W. (2019). Age mosaicism across multiple scales in adult tissues. Cell
Metab. 30, 343–351.e3.
Artner, I., Hang, Y., Guo, M., Gu, G., and Stein, R. (2008). MafA is a dedicated
activator of the insulin gene in vivo. J. Endocrinol. 198, 271–279.
Artner, I., Hang, Y., Mazur, M., Yamamoto, T., Guo, M., Lindner, J., Magnuson,
M.A., and Stein, R. (2010). MafA andMafB regulate genes critical to b-cells in a
unique temporal manner. Diabetes 59, 2530–2539.
Baker, D.J., Wijshake, T., Tchkonia, T., LeBrasseur, N.K., Childs, B.G., van de
Sluis, B., Kirkland, J.L., and van Deursen, J.M. (2011). Clearance of p16Ink4a-inB1 (red) decreased in MAFAS64F-expressing EndoC-bH2 cells.
d, purified and added to EndoC-bH2 cells cultured for 72 h. SASP genes up-
ever, novel, species-specific secretory senescence-associated factors were
0.01; ****p < 0.0001.
ssing male b cells. In male MafAS64F/+, transiently high MafA protein triggers
enescence staining (blue cytoplasmic shade), and initiation of a senescence-
ed GSIS. Late (progressive) senescence propagates this phenotype with SASP
Cell Reports 37, 109813, October 12, 2021 13
Article
ll
OPEN ACCESSpositive senescent cells delays ageing-associated disorders. Nature 479,
232–236.
Baker, D.J., Childs, B.G., Durik, M., Wijers, M.E., Sieben, C.J., Zhong, J., Salt-
ness, R.A., Jeganathan, K.B., Verzosa, G.C., Pezeshki, A., et al. (2016). Natu-
rally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature 530,
184–189.
Banerjee, R.R., Cyphert, H.A., Walker, E.M., Chakravarthy, H., Peiris, H., Gu,
X., Liu, Y., Conrad, E., Goodrich, L., Stein, R.W., and Kim, S.K. (2016). Gesta-
tional Diabetes Mellitus From Inactivation of Prolactin Receptor and MafB in
Islet b-Cells. Diabetes 65, 2331–2341.
Barbetti, F., and D’Annunzio, G. (2018). Genetic causes and treatment of
neonatal diabetes and early childhood diabetes. Best Pract. Res. Clin. Endo-
crinol. Metab. 32, 575–591.
Basisty, N., Meyer, J.G., and Schilling, B. (2018). Protein Turnover in Aging and
Longevity. Proteomics 18, e1700108.
Bergsten, P., Grapengiesser, E., Gylfe, E., Tengholm, A., and Hellman, B.
(1994). Synchronous oscillations of cytoplasmic Ca2+ and insulin release in
glucose-stimulated pancreatic islets. J. Biol. Chem. 269, 8749–8753.
Blum, B., Roose, A.N., Barrandon, O., Maehr, R., Arvanites, A.C., Davidow,
L.S., Davis, J.C., Peterson, Q.P., Rubin, L.L., andMelton, D.A. (2014). Reversal
of b cell de-differentiation by a small molecule inhibitor of the TGFb pathway.
eLife 3, e02809.
Bosco, D., Armanet, M., Morel, P., Niclauss, N., Sgroi, A., Muller, Y.D., Giovan-
noni, L., Parnaud, G., and Berney, T. (2010). Unique arrangement of a- and
b-cells in human islets of Langerhans. Diabetes 59, 1202–1210.
Brissova, M., Fowler, M.J., Nicholson, W.E., Chu, A., Hirshberg, B., Harlan,
D.M., and Powers, A.C. (2005). Assessment of human pancreatic islet archi-
tecture and composition by laser scanning confocal microscopy.
J. Histochem. Cytochem. 53, 1087–1097.
Butler, P.C., Meier, J.J., Butler, A.E., and Bhushan, A. (2007). The replication of
b cells in normal physiology, in disease and for therapy. Nat. Clin. Pract. Endo-
crinol. Metab. 3, 758–768.
Cabrera, O., Berman, D.M., Kenyon, N.S., Ricordi, C., Berggren, P.O., andCai-
cedo, A. (2006). The unique cytoarchitecture of human pancreatic islets has
implications for islet cell function. Proc. Natl. Acad. Sci. USA 103, 2334–2339.
Campisi, J. (2014). Cell biology: the beginning of the end. Nature 505, 35–36.
Campisi, J., and d’Adda di Fagagna, F. (2007). Cellular senescence: when bad
things happen to good cells. Nat. Rev. Mol. Cell Biol. 8, 729–740.
Camunas-Soler, J., Dai, X., Hang, Y., Bautista, A., Lyon, J., Suzuki, K., Kim, S.,
Quake, S., and MacDonald, P. (2020). Patch-Seq links single-cell transcrip-
tomes to human islet dysfunction in diabets. Cell Metab. 5, 1017–1031.
Chang, J., Wang, Y., Shao, L., Laberge, R.M., Demaria, M., Campisi, J., Jana-
kiraman, K., Sharpless, N.E., Ding, S., Feng, W., et al. (2016). Clearance of se-
nescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice.
Nat. Med. 22, 78–83.
Chen, C., Shiota, C., Agostinelli, G., Ridley, D., Jiang, Y., Ma, J., Prasadan, K.,
Xiao, X., and Gittes, G.K. (2019). Evidence of a developmental origin for b-cell
heterogeneity using a dual lineage-tracing technology. Development 146,
dev164913.
Childs, B.G., Baker, D.J., Wijshake, T., Conover, C.A., Campisi, J., and van
Deursen, J.M. (2016). Senescent intimal foam cells are deleterious at all stages
of atherosclerosis. Science 354, 472–477.
Conrad, E., Dai, C., Spaeth, J., Guo, M., Cyphert, H.A., Scoville, D., Carroll, J.,
Yu, W.M., Goodrich, L.V., Harlan, D.M., et al. (2016). The MAFB transcription
factor impacts islet a-cell function in rodents and represents a unique signa-
ture of primate islet b-cells. Am. J. Physiol. Endocrinol. Metab. 310, E91–E102.
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Guinea pig anti-Insulin Thermo Fisher Cat#PA1 26938; RRID:AB_794668
Mouse anti-Glucagon Sigma Cat#G2654; RRID:AB_259852
Mouse anti-Ki67 BD Biosciences Cat#550609; RRID:AB_393778
DAPI Fluoromount-G mounting medium SouthernBiotech Cat#0100-20
Rabbit anti-MAFA Cell Signaling Cat#79737; RRID:AB_2799938
Goat anti-PDX-1 Chris Wright, Vanderbilt N/A
Rabbit anti-UCN3 Phoenix Cat#H-019-028; RRID:AB_2889826
Goat anti-P21 (for cells) Santa Cruz Cat#sc-397G; RRID:AB_632127
Rat anti-P21 (for tissue sections) Abcam Cat#ab107099; RRID:AB_10891759
Rabbit anti-53BP1 Bethyl Cat#A300-272A; RRID:AB_185520
Rabbit anti-gH2AX Abcam Cat#ab81299; RRID:AB_1640564
Rabbit anti-LaminB1 Abcam Cat#16048; RRID:AB_443298
Bacterial and virus strains
Lentivirus: MAFAWT-pCDH-EF1-MCS-
IRES-GopGFP
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Chemicals, peptides, and recombinant proteins
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Critical commercial assays
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Senescence b-Galactosidase Staining Kit Cell Signaling Cat#9860
Glycogen Assay Kit Cayman Chemicals Cat#700480
Deposited data
Raw and analyzed data This paper GEO:GSE183561
Experimental models: Cell lines
Human: EndoC-bH2 Cells Scharfmann et al., 2014 N/A
Experimental models: Organisms/strains
Mouse: MafAS64F/+ This paper N/A
Oligonucleotides
Primers for mouse and human see Table S1 This paper N/A
Software and algorithms
Genialis visual informatics platform: BBDuk,
START aligner, featureCounts
https://www.genialis.com N/A
DESeq2 Love et al., 2014 N/A
ImageJ https://imagej.nih.gov/ij/ N/A
ImageScope Software Aperio Technologies N/ARESOURCE AVAILABILITY
Lead contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Roland




All unique/stable reagents generated in this study are available from the lead contact with a completed materials transfer agreement.
Data and code availability
d All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplemental information. Bulk
RNA-seq data have been deposited to GEO and are publicly available at the date of publication. Accession number is listed
in the Key resources table.
d This paper does not report original code.
d Any additional information required to reanalyze the data reported in this work paper is available from the Lead Contact upon
request.EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
S64FMafA-expressingmicewere generated usingCRISPR/Cas9 targeting by theUniversity ofMichigan TransgenicCore in theC57BL/
6J mouse strain. Viable animals and progeny were screened for the appropriate mutation by DNA sequencing (Molecular Resource
Center, University of Tennessee Health Science Center). Wild-type (WT) littermates were used as controls. MafAS64F/+ were born at
normalMendelian ratios while homozygousMafAS64F/S64F variants were not (see Figure S2).Mice of both sexes were used in this study;
details can be found in the results section and figure legends. All animal studies were reviewed and approved by the Vanderbilt Univer-
sity Institutional Animal Care and Use Committee. Mice were housed and cared for according to the Vanderbilt Department of Animal
Care and the Institutional Animal Care and Use Committee of Animal Welfare Assurance Standards and Guidelines.
Human EndoC-bH2 cells
Human EndoC-bH2 cells were grown in DMEMcontaining 5.6mMglucose, 2%BSA, 50 mM2-mercaptoethanol, 10mMnicotinamide,
5.5 mg/mL transferrin, 6.7 ng/mL selenite, 100 units/mL penicillin, and 100 units/mL streptomycin (Scharfmann et al., 2014). For gene
transfection, cells were incubated with lentiviral particles (150ng for cells cultured in a 6cm dish) containing either MAFAWT-express-
ing or MAFAS64F-expressing sequences one day after plating. Assays were performed one week following infection unless specified
otherwise.
METHOD DETAILS
Intraperitoneal glucose and insulin tolerance testing
Glucose tolerance testing was performed onWT andMafAS64F/+mice (n = 4-16) given an intraperitoneal injection of D-glucose (2mg/
g body weight) prepared in sterile PBS (20% w/v) after a 6-hour fast. Insulin tolerance tests were conducted by intraperitoneal injec-
tion of 0.5 IU/kg body weight insulin (Novolin, regular human insulin, recombinant DNA origin) into mice (n = 3-5) fasted for 6 hours.
Blood glucose was measured using a FreeStyle glucometer (Abbott Diabetes Care) before (0 minutes) and at 15, 30, 60, and 120 mi-
nutes following injection. Serum insulin was measured by radioimmunoassay at the Vanderbilt Hormone Assay and Analytical Ser-
vices Core using blood collected following the 6-hour fast. Serum testosterone was measured by the University of Virginia Center for
Research in Reproduction Ligand Assay and Analysis Core.
Glucose-stimulated hormone secretion
WT and MafAS64F/+ mouse (n = 3-6) islets were isolated using standard islet isolation conditions, and hormone secretion was as-
sessed as described previously (Cyphert et al., 2019). The outcome was presented as secreted insulin or glucagon relative to the
total islet DNA content (ng/mg DNA (insulin) or pg/mg DNA (glucagon)). Islet hormone content was presented as the concentration
of insulin or glucagon per DNA content (Quant-iT PicoGreen, Invitrogen) in each reaction (ng/ng DNA).
For perifusion analysis, islets from 8-10 week old female and male WT and MafAS64F/+ mice were studied in a dynamic cell peri-
fusion system at a perifusate flow rate of 1 mL/min (Walker et al., 2020) in the Vanderbilt Islet Procurement and Analysis Core. The
effluent was collected at 3-minute intervals using an automatic fraction collector. The insulin concentration in each perifusion fraction
and islet extract was measured by radioimmunoassay (Millipore).
Tissue and cell preparation and immunostaining
For immunostaining, WT andMafAS64F/+ pancreata were fixed in 4% (v/v) paraformaldehyde, embedded in either Tissue-Plus O.C.T.
(Thermo Fisher Scientific) or paraffin wax, and sectioned to 6 mm thickness. Immunofluorescent images were obtained using a Zeiss
Axio Imager M2widefield microscope with ApoTome. Immunofluorescence staining was performed as previously described with the
antibodies listed in Key resources table. Islet b- and a- cell areas were determined as described previously (Cyphert et al., 2019).
Briefly, pancreatic sections taken every 50 mm (n = 3-4 animals per genotype) were scanned using a ScanScope CS scanner (AperioCell Reports 37, 109813, October 12, 2021 e2
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CA). Islet b- and a-cell areas were calculated as the ratio of the insulin- or glucagon-positive area to total pancreas area (eosin
stained). The TUNEL assay was performed using an in situ cell death detection kit (Roche, #11684795910). In EndoC-bH2 cells, im-
munostaining for LaminB1, 53BP1, and p21 were also performed (see Key resources table).
RNA sequencing, analysis, and validation by quantitative real-time PCR
RNAwas isolated fromWT andMafAS64F/+ islets (n = 4 each for males, n = 5 each for females) using the RNAqueous total RNA isolation
kit (Ambion; Thermo Fisher), and then analyzed on an Agilent 2100 Bioanalyzer. Only samples with an RNA Integrity Number > 8.0 were
used for library preparation. cDNA librarieswere constructed and paired-end sequencing of 4-5 replicateswas performed on an Illumina
NovaSeq6000 (150 nucleotide reads). The generated FASTQ files were processed and interpreted using the Genialis visual informatics
platform (https://www.genialis.com). Reads were preprocessed by BBDuk which removes adapters, trims reads for quality from the 30
end, and discards reads that are too short after trimming. Preprocessed reads were aligned by START aligner and quantification was
done using featureCounts. FastQC reports, alignment statistics and rRNA/globin depletion rate QC information is automatically sum-
marized by the MultiQC tool. Differential gene expression analyses were performed with DESeq2 (Love et al., 2014) with a log2(fold
change) threshold of 1 and FDR < 0.05 using the genomebuild GRCm38. Tab-delimited text files include FPKMvalues for each sample.
Quantitative real-time PCR expression analysis of selected candidates were performed on independently isolated mouse islets
and EndoC-bH2 cells. Trizol reagent (Life Technologies) was used to collect RNA. The cDNAs produced from the iScript cDNA Syn-
thesis Kit (Bio-Rad) were processed in a LightCycler 480 II system (Roche), and analyzed by the DDCTmethod with primers provided
in Key resources table. Significance was calculated by comparing the DCT values.
Islet cytosolic calcium imaging
Approximately 60WT andMafAS64F/+ islets from at least 6 female andmale mice were analyzed with the ratiometric calcium indicator
fura-2-acetoxymethylester (Fura-2 AM) (Life Technologies). Islets were maintained in 5 mM glucose culture media for 30 min prior to
being loaded with 2 mM Fura-2 AM for 20 min, washed, transferred to a hand-made agarose gel small-volume chamber in a glass
bottom dish filled with regular HBSS (5 mM glucose, Thermo Fisher). The 11 mM glucose-induced calcium oscillations and depolar-
ization-activated calcium influx at 30 mM KCl were measured. Images were taken using a Nikon Eclipse TE2000-U microscope
equipped with an epifluorescence illuminator (SUTTER, Inc), a CCD camera (HQ2; Photometrics, Inc), and Nikon Elements software
(NIKON, Inc) as described before (Dadi et al., 2015).
Senescence-associated b-galactosidase (SA-b-gal) staining
WTandMafAS64F/+ pancreata were snap frozen in O.C.T. and cryosections were prepared at 16 mm thickness. SA-b-gal activity stain-
ing was performed at pH 6.0 (Kurz et al., 2000) using a commercial kit (Cell Signaling, #9860). To compare the intensity of SA-b-gal
staining, sections from different genotypes and ages were processed on the same slide. Staining reactions were developed for 18
hours at 37C, then stopped by 3x PBS washes (pH 7.4). Slides were then subject to immunostaining for insulin by fixing in 4% para-
formaldehyde for 45 minutes, permeabilized with Tris-buffered saline with 0.2% Triton X-100 for 15 minutes, blocked in 2% normal
donkey serum/1%BSA in PBS and incubated overnight with guinea pig anti-insulin (1:500, Abcam) at 4C. HRP-conjugated second-
ary antibodies were incubated on slides for 1 hour and detected with the DAB+ chromogen kit (DAKO). After washing, slides were
mounted and imaged by brightfield microscopy. The total number of SA-b-gal+ islets per pancreas section were analyzed on ImageJ.
The same kit and condition were also used to evaluate the SA-b-gal activity in EndoC-bH2 cells cultured on chamber slides from
different conditions. Staining reactions were stopped after developing for 2 to 3 hours at 37C with 3x PBS washes (pH 7.4). Slides
were then subject to immunostaining for MAFA by fixing in 4% paraformaldehyde for 12 minutes, permeabilized with Tris-buffered
saline with 0.5% Triton X-100 for 5 minutes, blocked in 2% normal donkey serum/1%BSA in PBS and incubated overnight with Rab-
bit a-MAFA (1:500, Novus (NBP1-00121) at 4C. After washing, slides weremounted and imaged on a Zeiss Axio ImagerM2widefield
microscope with ApoTome. Average SA-b-gal+ area/cell was analyzed on ImageJ.
Ovariectomy methods
WT andMafAS64F/+ femalemice underwent ovariectomy at 3 weeks to remove the contribution of endogenous ovarian hormones and
prevent completion of sexual maturity (Martinez et al., 2012). Mice were anesthetized with 1%–5% inhaled isoflurane, and placed
prone on a heating pad to maintain their body temperature at 37C. The mice received subcutaneous ketofen at 5-10 mg/kg prior
to surgery and post-operatively for two days for pain relief. Intraperitoneal ceftriaxone at 20-40mg/kgwas given once intraoperatively
for infection prophylaxis. After adequate anesthesia and analgesia, a midline 1.5 cm incision was made along the shaved mid-dorsal
surface of the mouse. Within the retroperitoneal cavity, the ovaries were located and ligated. The incision was closed using surgical
staples, which were removed on post-operative day three. Micewere housed singly during recovery and regrouped post-operatively.
Glycogen storage assay
Liver and gastrocnemius muscle fromWT andMafAS64F/+ mice (n = 5 per genotype and sex) were collected and flash frozen in liquid
nitrogen. Tissue was homogenized with a Dounce homogenizer prior to determining glycogen content using a glycogen assay kit
(Cayman Chemical) according to the manufacturer’s protocol.e3 Cell Reports 37, 109813, October 12, 2021
Article
ll
OPEN ACCESSParacrine conditioned media assay
Conditioned media (CM) produced after 24 hours of culture fromMAFAS64F- and MAFAWT-expressing human EndoC-bH2 cells were
clarified by centrifugation at 500xg for 5 minutes and then at 3000xg for 5 minutes. CM was stored at 4C for up to 3 weeks prior to
use. EndoC-bH2 cells plated on 12-well plate were cultured with a 1:1 mix of EndoC-bH2 islet media (4% BSA) and albumin-free CM
collected from MAFAWT or MAFAS64F expressing cells (resulting in 2% BSA in the final medium). For controls, EndoC-bH2 cells from
the same passage were cultured in a 1:1 mix of regular EndoC-bH2 cells media and albumin-free media alone (not conditioned by
cells), also resulting in 2% BSA in the final medium. After 72 hours, EndoC-bH2 cells were harvested for analysis.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical significance was determined using the two-tailed Student t test, one-way ANOVA or two-way ANOVA and Tukey post hoc
test as indicated in the figure legends. Data are presented as the mean ± SEM. A threshold of at least p < 0.05 was used to declare
significance.Cell Reports 37, 109813, October 12, 2021 e4
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Figure S1: Glucose tolerance phenotypes were stably maintained in male and female 
MafAS64F/+ mice. Related to Figure 1. GTT was performed in 3-, 6-, 7-, and 16-week-old mice.  
Glucose (2mg/kg) was injected following a 6 hour fast and blood glucose was measured at the 
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Observed Expected Chi2 p-value
WT 57 37.5 p<0.01
Het 82 75 n.s.
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Figure S2: Homozygous male MafAS64F/S64F mice were hyperglycemic, with glucose 
tolerance and blood glucose levels worsening with age. Related to Figure 1. a) MafAS64F/S64F
mice showed progressively worsening glucose tolerance and fasting blood glucose levels between 
5 to 10 weeks of age. b) Fasting blood glucose levels in homozygous male mutant mice increased 
significantly over time. c) Female S64F MafA homozygous mice were only mildly glucose intolerant 
at 10 weeks of age although their temporal responses to glucose was variable between animals. d) 
Chi-square analysis revealed that MafAS64F/S64F male and female animals were observed with 
significantly less frequency at weaning than WT animals. In contrast, MafAS64F/+ numbers were as 
expected. Two-tail Student t test; *p<0.05; **p<0.01; ***p<0.001. 
*
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Figure S3: Female and male MafAS64F/+ islets secreted more insulin in response to high 
glucose with decreased proliferation and no change in glucagon secretion. Related to 
Figure 1. a) Islet perifusion demonstrated islets from MafAS64F/+ female mice secreted higher levels 
of insulin at low (G 5.6) and high (G 16.7) glucose and in response to KCl. b) Serum insulin levels 
(ng/mL) were higher in 6-hour fasted female MafAS64F/+ animals while male MafAS64F/+ levels were 
unchanged. c) Islet perifusion results from MafAS64F/+ male mice at high (G 16.7) glucose and in 
response to KCl. Islets were isolated from 8-10 week-old animals in both genders. Glucagon 
secretion (d) and content (e) were unchanged in MafAS64F/+ islets, which were incubated in 4.6 mM 
(LG) and 16.7 mM (HG) glucose for 1 hour prior to collection. Secretion and content were 
normalized to DNA. f) Islet a cell area was not reduced in male or female MafAS64F/+ mice, though 
measurements were highly variable between samples. Islet a cell area was calculated by dividing 
the total glucagon+ area by the total pancreas area (eosin staining) multiplied by 100 to obtain 
percent (%). Two-way ANOVA. g) Representative islets stained for insulin, Ki67 (proliferation 
marker), and DAPI (nuclei). Islet β cell proliferation was calculated by dividing the number of Ki67+
cells by total insulin+ β cells.  Greater than 1000 β cells were counted per animal. h) β cell number 
per islet section was significantly reduced in MafAS64F/+ male mice calculated by dividing the total 
number of Insulin+ cells by the number of islet sections (n ≥ 20 islets per sample) quantitated. Two-
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Figure S4: Insulin tolerance and glycogen content are unaltered in MafAS64F/+ animals.
Related to Figure 1. a) Insulin tolerance was unchanged at 4 and 5 weeks in MafAS64F/+ animals 
once corrected for initial fasted blood glucose levels (Percent of 0 min). Insulin (0.5U/kg body 
weight) was injected following a 6-hour fast. b) Glycogen content in muscle (soleus) and liver, 
normalized to wet tissue weight, was also unaffected in 7-week-old MafAS64F/+ mice. c) There was 
no change in average body weight between 3-6 weeks except a small decrease (-1.07-fold) in 
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MAFA is NOT increased in female β cells 

































































Figure S5: Ovariectomy (OVX) did not alter glucose tolerance in female MafAS64F/+ mice, nor 
are testosterone levels changed while male MafAS64F/+ islets had a reduced response to KCl
stimulation. Related to Figures 1 and 4. a) Compared to 4-week-old control mice (i.e., non OVX: 
WT, grey line; Het, teal line), the GTT at 1-week post ovariectomy showed glucose intolerance in 
WT female mice (WT OVX, purple line) and no change in MafAS64F/+ mice (Het OVX, orange line). 
One-way ANOVA; WT vs. WT OVX: *p<0.05; Het vs. WT OVX: $p<0.05; $$p<0.01; WT vs. Het: 
##p<0.01; ####p<0.0001; WT vs. Het OVX: @p<0.05; @@p<0.01. b) Serum testosterone levels were 
unchanged in male or female MafAS64F/+ mice. Male and female testosterone levels are similar at 4 
and 5 weeks of age. Two-way ANOVA. c) Representative Ca2+ traces quantitated in Figure 4c in 
response to both high glucose (9 mM) and KCl (30 mM). d) Female MafAS64F/+ islets have 
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Figure S6: qPCR confirmation of changes in islet gene expression identified by RNA-seq. 
Related to Figure 5. a) Senescence markers were primarily unchanged in female MafAS64F/+ islets. 
b-c) Genes altered specifically in female MafAS64F/+ islets (b) identified by RNA-seq were mostly 













































Figure S7: DNA damage and cell cycle inhibition markers were not detected in 5-week-old 
female MafAS64F/+ islets, nor were significant levels of apoptosis found in MafAS64F/+ islet 
cells. Related to Figure 6. a-e) Changes in immunostaining for gH2AX (DNA double strand break; 
a), 53BP1 (DNA double strand break; b), p21 (cell cycle inhibitor; c), LaminB1 protein (nuclear 
integrity marker; d) and endogenous staining for SA-β-gal (senescence marker; e) were not altered 
in female MafAS64F/+ islets. f) TUNEL+ nuclei were barely detected in MafAS64F/+ islets at 6 weeks of 















Figure S8: MAFAS64F expressing human cells have changes in DNA damage, senescence, 
and Ca2+ channel gene expression. Related to Figure 7. a) Western blotting for EndoC-βH2 
cells transduced to express WT MAFA or MAFAS64F shows faster migration in the MAFAS64F lane 
consistent with under-phosphorylated MAFA. Higher MAFAS64F protein level is likely due to 
increased MAFA protein stability seen in (Iacovazzo et al., 2018). b) 53BP1 staining (left) intensity 
was higher and LaminB1 staining (right) intensity was lower in MAFAS64F expressing EndoC-βH2 
cells compared with MAFAWT. c) qRT-PCR for Ca2+ channel genes (left) showed some alterations in 
MAFAS64F expressing EndoC-βH2 cells while no changes in insulin secretion machinery genes 


















































































Figure S9: Many X chromosome linked genes were altered in male MafAS64F/+ islets and 
production of some β cell identity gene products are downregulated in both male and 
female MafAS64F/+ islets. Related to Figure 3. a) Heat map developed from the 5-week-old islet 
RNA-Seq data. FDR<0.05. b) Heat map showing β identity genes decreased in both male and 
female Het islets. FDR<0.05. c) Immunostaining illustrating decreased Pdx1 and Ucn3 protein 
levels in 7-week-old Het islets.
Table S1: Primer information
Mouse primers Forward Reverse
MafA CCTGTAGAGGAAGCCGAGGAA CCTCCCCCAGTCGAGTATAGC 
Ins1 CACTTCCT ACCCCTGCTGG ACCACAAAGATGCTGTTTGACA 
pre-Ins2 GGGGAGCGTGGCTTCTTCTA GGGGACAGAATTCAGTGGCA 
Ins2 CCACCCAGGCTTTTGTCAAA CCCAGCTCCAGTTGTTCCAC 
Pdx1 CGGCTGAGCAAGCTAAGGTT TGGAAGAAGCGCTCTCTTTGA 

















18S rRNA GTAACCCGTTGAACCCCATT CCATCCAATCGGTAGTAGCG
Lmnb1 CAGGAATTGGAGGACATGCT GAAGGGCTTGGAGAGAGCTT
b-Actin AGGTCATCACTATTGGCAACGA CACTTCATGATGGAATTGAATGTAGTT

















LMNB1 TGGAGTGG TTGTTGAGGAAG GAGAAGGCTCTGCACTGTATAC
CACNA1A CTGGTAGCCTTTGCCTTCACTG ACACAGCCTTGAGCTTTGGCAG
CACNA1C GCAGGAGTACAAGAACTGTGAGC CGAAGTAGGTGGAGTTGACCAC
CACNA1E AGCGTGAGACAGGCAAAGCCAT GGATGCACATCTCAAAGTAGCGC
CACNA1G TTCACCGCAGTCTTTCTGGCTG TGACGGAGATGAGCACCAACAG
EXOC3 GAGCCATTGCTTTCTCCACACG TGGCTCTGTCTCTTTGACCCAG
EXOC5 CTTCAGTAATCCAGAAACAGTCCT TGCTCTGCATCGGACTTCCTAC
SNAP25 CGTCGTATGCTGCAACTGGTTG GGTTCATGCCTTCTTCGACACG
VAMP2 CTCCAAACCTCACCAGTAACAGG AGCTCCGACAGCTTCTGGTCTC
STX1A GGAACACGCGGTAGACTATGT CTGGAGTGGAGTGGCAGTTT
KCNJ11 TGTGTCACCAGCATCCACTCCT GTTCTGCACGATGAGGATCAGG
GAPDH CTCACCGGATGCACCAATGTT CGCGTTGCTCACAATGTTCAT
